Therefore, it is tempting to speculate that the barttin-dependent regulation of ClC-5 trafficking and processing is altered not only by mutation G261E but also by other DD1 mutations and contributes to hypokalemia progression in the affected patients. The gene discussed is AKR1C1; the disease is Hypokalemia.